ArticleCureus2026
Exfoliative Erythroderma Revealing Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exfoliative erythroderma is a severe inflammatory skin condition that may result from pre-existing dermatoses, medications, or underlying malignancy. Although malignancy-associated cases are uncommon, persistent and treatment-resistant erythroderma should raise concern for an occult cancer. We report the case of an 82-year-old man with a one-year history of diffuse pruritic erythema and scaling involving nearly the entire body surface area that remained refractory to multiple dermatologic and immunosuppressive therapies. Initial evaluation for cutaneous lymphoma and systemic malignancy was negative. Months later, the patient developed a generalized seizure, and a brain MRI revealed a right frontal lobe mass. Biopsy later confirmed Epstein-Barr virus-positive primary central nervous system diffuse large B-cell lymphoma. This case highlights persistent exfoliative erythroderma as a potential paraneoplastic manifestation of an underlying malignancy and emphasizes the importance of continued evaluation for occult cancer when erythroderma remains unexplained and refractory to treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.